Which has stronger valuation and earnings, IRIX or XAIR?

IRIDEX has higher revenue and earnings than Beyond Air. IRIDEX is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IRIDEX $52.67M 0.21 -$4.44M -$0.20 N/A Beyond Air $7.69M 0.38 -$33.25M -$68.40 N/A

Is IRIX or XAIR more profitable?

IRIDEX has a net margin of -6.88% compared to Beyond Air's net margin of -435.71%. IRIDEX's return on equity of 0.00% beat Beyond Air's return on equity. Company Net Margins Return on Equity Return on Assets IRIDEX -6.88% N/A -12.55% Beyond Air -435.71% -440.26% -98.50%

Is ADGM or XAIR more profitable?

Adagio Medical has a net margin of 0.00% compared to Beyond Air's net margin of -435.71%. Beyond Air's return on equity of -440.26% beat Adagio Medical's return on equity. Company Net Margins Return on Equity Return on Assets Adagio Medical N/A -661.85% -73.35% Beyond Air -435.71% -440.26% -98.50%

Do analysts prefer XAIR or MBAI?

Beyond Air presently has a consensus target price of $105.00, suggesting a potential upside of 3,388.37%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts clearly believe Beyond Air is more favorable than Check-Cap. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beyond Air 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Check-Cap 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is XAIR or MBAI more profitable?

Check-Cap has a net margin of 0.00% compared to Beyond Air's net margin of -435.71%. Check-Cap's return on equity of 0.00% beat Beyond Air's return on equity. Company Net Margins Return on Equity Return on Assets Beyond Air -435.71% -440.26% -98.50% Check-Cap N/A N/A N/A

Is SINT or XAIR more profitable?

Beyond Air has a net margin of -435.71% compared to Sintx Technologies' net margin of -848.20%. Sintx Technologies' return on equity of -354.44% beat Beyond Air's return on equity. Company Net Margins Return on Equity Return on Assets Sintx Technologies -848.20% -354.44% -115.37% Beyond Air -435.71% -440.26% -98.50%

Beyond Air (XAIR) Competitors

$3.01 -0.19 (-5.94%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$3.06 +0.05 (+1.50%)

As of 04:08 AM Eastern

Compare

XAIR vs. IRIX, ADGM, MBAI, NDRA, and SINT

Should you buy Beyond Air stock or one of its competitors? Beyond Air's main competitors and comparable companies include IRIDEX (IRIX), Adagio Medical (ADGM), Check-Cap (MBAI), ENDRA Life Sciences (NDRA), and Sintx Technologies (SINT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Beyond Air compare to IRIDEX?

IRIDEX (NASDAQ:IRIX) and Beyond Air (NASDAQ:XAIR) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation and earnings.

IRIDEX has higher revenue and earnings than Beyond Air. IRIDEX is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.21	-$4.44M	-$0.20	N/A
Beyond Air	$7.69M	0.38	-$33.25M	-$68.40	N/A

In the previous week, IRIDEX had 2 more articles in the media than Beyond Air. MarketBeat recorded 2 mentions for IRIDEX and 0 mentions for Beyond Air. IRIDEX's average media sentiment score of 0.06 beat Beyond Air's score of 0.00 indicating that IRIDEX is being referred to more favorably in the media.

Company	Overall Sentiment
IRIDEX	Neutral
Beyond Air	Neutral

20.1% of IRIDEX shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 8.6% of IRIDEX shares are owned by insiders. Comparatively, 10.0% of Beyond Air shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

IRIDEX has a beta of 0.62, indicating that its stock price is 38% less volatile than the broader market. Comparatively, Beyond Air has a beta of 0.13, indicating that its stock price is 87% less volatile than the broader market.

IRIDEX has a net margin of -6.88% compared to Beyond Air's net margin of -435.71%. IRIDEX's return on equity of 0.00% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.88%	N/A	-12.55%
Beyond Air	-435.71%	-440.26%	-98.50%

IRIDEX currently has a consensus target price of $3.00, suggesting a potential upside of 373.19%. Beyond Air has a consensus target price of $105.00, suggesting a potential upside of 3,388.37%. Given Beyond Air's stronger consensus rating and higher probable upside, analysts plainly believe Beyond Air is more favorable than IRIDEX.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

IRIDEX beats Beyond Air on 9 of the 16 factors compared between the two stocks.

How does Beyond Air compare to Adagio Medical?

Adagio Medical (NASDAQ:ADGM) and Beyond Air (NASDAQ:XAIR) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, risk and dividends.

In the previous week, Adagio Medical had 3 more articles in the media than Beyond Air. MarketBeat recorded 3 mentions for Adagio Medical and 0 mentions for Beyond Air. Beyond Air's average media sentiment score of 0.00 beat Adagio Medical's score of -0.01 indicating that Beyond Air is being referred to more favorably in the news media.

Company	Overall Sentiment
Adagio Medical	Neutral
Beyond Air	Neutral

48.1% of Adagio Medical shares are held by institutional investors. Comparatively, 31.5% of Beyond Air shares are held by institutional investors. 7.8% of Adagio Medical shares are held by insiders. Comparatively, 10.0% of Beyond Air shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Adagio Medical has a net margin of 0.00% compared to Beyond Air's net margin of -435.71%. Beyond Air's return on equity of -440.26% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adagio Medical	N/A	-661.85%	-73.35%
Beyond Air	-435.71%	-440.26%	-98.50%

Adagio Medical presently has a consensus price target of $3.50, suggesting a potential upside of 1,435.09%. Beyond Air has a consensus price target of $105.00, suggesting a potential upside of 3,388.37%. Given Beyond Air's stronger consensus rating and higher probable upside, analysts plainly believe Beyond Air is more favorable than Adagio Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Adagio Medical has higher earnings, but lower revenue than Beyond Air. Adagio Medical is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adagio Medical	N/A	N/A	-$25.08M	-$1.48	N/A
Beyond Air	$7.69M	0.38	-$33.25M	-$68.40	N/A

Adagio Medical has a beta of -0.09, suggesting that its share price is 109% less volatile than the broader market. Comparatively, Beyond Air has a beta of 0.13, suggesting that its share price is 87% less volatile than the broader market.

Summary

Beyond Air beats Adagio Medical on 9 of the 15 factors compared between the two stocks.

How does Beyond Air compare to Check-Cap?

Beyond Air (NASDAQ:XAIR) and Check-Cap (NASDAQ:MBAI) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, profitability, analyst recommendations, media sentiment, earnings and institutional ownership.

Check-Cap has a net margin of 0.00% compared to Beyond Air's net margin of -435.71%. Check-Cap's return on equity of 0.00% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beyond Air	-435.71%	-440.26%	-98.50%
Check-Cap	N/A	N/A	N/A

Beyond Air has a beta of 0.13, indicating that its share price is 87% less volatile than the broader market. Comparatively, Check-Cap has a beta of 0.67, indicating that its share price is 33% less volatile than the broader market.

Beyond Air presently has a consensus target price of $105.00, suggesting a potential upside of 3,388.37%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts clearly believe Beyond Air is more favorable than Check-Cap.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Check-Cap	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

31.5% of Beyond Air shares are owned by institutional investors. Comparatively, 1.1% of Check-Cap shares are owned by institutional investors. 10.0% of Beyond Air shares are owned by insiders. Comparatively, 0.5% of Check-Cap shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Check-Cap has lower revenue, but higher earnings than Beyond Air. Check-Cap is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beyond Air	$7.69M	0.38	-$33.25M	-$68.40	N/A
Check-Cap	N/A	N/A	$4.14M	-$14.07	N/A

In the previous week, Check-Cap had 1 more articles in the media than Beyond Air. MarketBeat recorded 1 mentions for Check-Cap and 0 mentions for Beyond Air. Beyond Air's average media sentiment score of 0.00 equaled Check-Cap'saverage media sentiment score.

Company	Overall Sentiment
Beyond Air	Neutral
Check-Cap	Neutral

Summary

Beyond Air and Check-Cap tied by winning 7 of the 14 factors compared between the two stocks.

How does Beyond Air compare to ENDRA Life Sciences?

ENDRA Life Sciences (NASDAQ:NDRA) and Beyond Air (NASDAQ:XAIR) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, media sentiment, valuation and analyst recommendations.

ENDRA Life Sciences has a net margin of 0.00% compared to Beyond Air's net margin of -435.71%. ENDRA Life Sciences' return on equity of -246.34% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ENDRA Life Sciences	N/A	-246.34%	-150.81%
Beyond Air	-435.71%	-440.26%	-98.50%

ENDRA Life Sciences has higher earnings, but lower revenue than Beyond Air. ENDRA Life Sciences is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ENDRA Life Sciences	N/A	N/A	-$7.03M	-$6.38	N/A
Beyond Air	$7.69M	0.38	-$33.25M	-$68.40	N/A

ENDRA Life Sciences has a beta of -0.05, meaning that its stock price is 105% less volatile than the broader market. Comparatively, Beyond Air has a beta of 0.13, meaning that its stock price is 87% less volatile than the broader market.

In the previous week, ENDRA Life Sciences' average media sentiment score of 0.00 equaled Beyond Air'saverage media sentiment score.

Company	Overall Sentiment
ENDRA Life Sciences	Neutral
Beyond Air	Neutral

ENDRA Life Sciences currently has a consensus price target of $25.00, indicating a potential upside of 284.62%. Beyond Air has a consensus price target of $105.00, indicating a potential upside of 3,388.37%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts clearly believe Beyond Air is more favorable than ENDRA Life Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ENDRA Life Sciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

1.2% of ENDRA Life Sciences shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 10.0% of ENDRA Life Sciences shares are owned by insiders. Comparatively, 10.0% of Beyond Air shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Beyond Air beats ENDRA Life Sciences on 8 of the 13 factors compared between the two stocks.

How does Beyond Air compare to Sintx Technologies?

Sintx Technologies (NASDAQ:SINT) and Beyond Air (NASDAQ:XAIR) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, earnings, dividends, analyst recommendations, valuation and profitability.

In the previous week, Sintx Technologies had 2 more articles in the media than Beyond Air. MarketBeat recorded 2 mentions for Sintx Technologies and 0 mentions for Beyond Air. Sintx Technologies' average media sentiment score of 0.12 beat Beyond Air's score of 0.00 indicating that Sintx Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
Sintx Technologies	Neutral
Beyond Air	Neutral

18.4% of Sintx Technologies shares are held by institutional investors. Comparatively, 31.5% of Beyond Air shares are held by institutional investors. 4.1% of Sintx Technologies shares are held by insiders. Comparatively, 10.0% of Beyond Air shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Sintx Technologies has higher earnings, but lower revenue than Beyond Air. Sintx Technologies is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sintx Technologies	$1.09M	7.09	-$10.36M	-$4.91	N/A
Beyond Air	$7.69M	0.38	-$33.25M	-$68.40	N/A

Beyond Air has a net margin of -435.71% compared to Sintx Technologies' net margin of -848.20%. Sintx Technologies' return on equity of -354.44% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sintx Technologies	-848.20%	-354.44%	-115.37%
Beyond Air	-435.71%	-440.26%	-98.50%

Sintx Technologies currently has a consensus price target of $9.33, suggesting a potential upside of 424.34%. Beyond Air has a consensus price target of $105.00, suggesting a potential upside of 3,388.37%. Given Beyond Air's higher probable upside, analysts plainly believe Beyond Air is more favorable than Sintx Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sintx Technologies	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Beyond Air beats Sintx Technologies on 7 of the 13 factors compared between the two stocks.

Get Beyond Air News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XAIR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

XAIR vs. The Competition

Export

Metric	Beyond Air	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$3.06M	$5.58B	$7.31B	$13.29B
Dividend Yield	N/A	1.79%	2.52%	12.57%
P/E Ratio	-0.04	25.27	274.09	25.69
Price / Sales	0.38	71.58	642.55	79.71
Price / Cash	N/A	33.02	77.80	52.76
Price / Book	0.32	5.78	10.47	6.32
Net Income	-$33.25M	$151.55M	$3.49B	$359.73M
7 Day Performance	-2.27%	0.01%	-0.68%	0.17%
1 Month Performance	-38.70%	-3.51%	-3.18%	-3.27%
1 Year Performance	-93.88%	6.37%	15.12%	5.58%

Beyond Air Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
XAIR Beyond Air	2.9216 of 5 stars	$3.01 -5.9%	$105.00 +3,388.4%	-93.5%	$3.06M	$7.69M	N/A	54
IRIX IRIDEX	1.7612 of 5 stars	$0.65 +1.1%	$3.00 +363.7%	-46.7%	$11.37M	$51.57M	N/A	120	News Coverage
ADGM Adagio Medical	2.6979 of 5 stars	$0.47 +2.6%	$3.50 +638.4%	-88.8%	$10.53M	$600K	N/A	87	News Coverage Gap Down
MBAI Check-Cap	0.1889 of 5 stars	$6.43 -1.0%	N/A	N/A	$8.87M	N/A	N/A	80
NDRA ENDRA Life Sciences	1.8797 of 5 stars	$5.43 -3.0%	$25.00 +360.1%	+37.0%	$7.99M	N/A	N/A	20

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:XAIR) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Beyond Air (XAIR) Competitors

XAIR vs. IRIX, ADGM, MBAI, NDRA, and SINT

How does Beyond Air compare to IRIDEX?

Summary

How does Beyond Air compare to Adagio Medical?

Summary

How does Beyond Air compare to Check-Cap?

Summary

How does Beyond Air compare to ENDRA Life Sciences?

Summary

How does Beyond Air compare to Sintx Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XAIR vs. The Competition

Beyond Air Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Beyond Air (XAIR) Competitors

XAIR vs. IRIX, ADGM, MBAI, NDRA, and SINT

How does Beyond Air compare to IRIDEX?

Which has stronger valuation and earnings, IRIX or XAIR?

Does the media favor IRIX or XAIR?

Do insiders & institutionals hold more shares of IRIX or XAIR?

Which has more risk & volatility, IRIX or XAIR?

Is IRIX or XAIR more profitable?

Do analysts prefer IRIX or XAIR?

Summary

How does Beyond Air compare to Adagio Medical?

Does the media prefer ADGM or XAIR?

Do insiders & institutionals hold more shares of ADGM or XAIR?

Is ADGM or XAIR more profitable?

Do analysts recommend ADGM or XAIR?

Which has preferable earnings and valuation, ADGM or XAIR?

Which has more risk and volatility, ADGM or XAIR?

Summary

How does Beyond Air compare to Check-Cap?

Is XAIR or MBAI more profitable?

Which has more risk & volatility, XAIR or MBAI?

Do analysts prefer XAIR or MBAI?

Do insiders and institutionals hold more shares of XAIR or MBAI?

Which has stronger valuation and earnings, XAIR or MBAI?

Does the media favor XAIR or MBAI?

Summary

How does Beyond Air compare to ENDRA Life Sciences?

Is NDRA or XAIR more profitable?

Which has better valuation & earnings, NDRA or XAIR?

Which has more volatility and risk, NDRA or XAIR?

Does the media favor NDRA or XAIR?

Do analysts rate NDRA or XAIR?

Do institutionals & insiders have more ownership in NDRA or XAIR?

Summary

How does Beyond Air compare to Sintx Technologies?

Does the media favor SINT or XAIR?

Do institutionals & insiders have more ownership in SINT or XAIR?

Which has preferable earnings & valuation, SINT or XAIR?

Is SINT or XAIR more profitable?

Do analysts prefer SINT or XAIR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XAIR vs. The Competition

Beyond Air Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools